New to the UK?
Entering the UK market can be complex, particularly when navigating MHRA requirements and understanding how UK regulatory pathways differ from other regions.
At Fusion Pharma, we support pharmaceutical and biotech companies that are new to the UK, providing practical guidance from regulatory strategy through to submission, approval and launch readiness. Whether you are applying for a UK marketing authorisation, becoming the Marketing Authorisation Holder, or preparing to bring an approved product to market, we can help you understand what needs to be in place and when.
We help you:
- Understand MHRA requirements and expectations
- Define the most appropriate UK regulatory pathway
- Prepare and manage UK regulatory submissions
- Understand the role and responsibilities of the Marketing Authorisation Holder
- Plan for UK launch requirements, including supply chain and batch release considerations
- Coordinate key support services, including pharmacovigilance, medical information and UK batch release/MIA arrangements
- Support market access planning, including pricing, reimbursement, procurement and route-to-market considerations
- Identify what needs to be ready before approval, so launch planning does not become an afterthought
Getting a product approved is essential, but approval alone does not mean a product is ready to launch. UK market entry requires early planning across regulatory strategy, dossier readiness, supply chain, pharmacovigilance, medical information, batch release and market access.
Through our regulatory expertise and trusted partner network, Fusion Pharma helps clients move from strategy to launch with confidence, with the right regulatory, operational and commercial considerations planned early and managed practically.
With experience across UK medicines regulation and direct interaction with the MHRA, we provide clear, practical support to help you bring products to the UK market efficiently and effectively.